(Q46241666)

20 December 2017

title

Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells (English)

1 reference

20 December 2017

0 references

0 references

11

1 reference

20 December 2017

author name string

M Sottili

1

1 reference

20 December 2017

L Cosmi

2

1 reference

20 December 2017

E Borgogni

3

1 reference

20 December 2017

E Sarchielli

4

1 reference

20 December 2017

L Maggi

5

1 reference

20 December 2017

M Francalanci

6

1 reference

20 December 2017

G B Vannelli

7

1 reference

20 December 2017

E Ronconi

8

1 reference

20 December 2017

L Adorini

9

1 reference

20 December 2017

F Annunziato

10

1 reference

20 December 2017

M Serio

12

1 reference

20 December 2017

C Crescioli

13

1 reference

20 December 2017

language of work or name

English

0 references

publication date

5 November 2008

1 reference

20 December 2017

Experimental Cell Research

published in

1 reference

20 December 2017

volume

315

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

264-273

1 reference

20 December 2017

Immunosuppressive drugs for kidney transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Drug Therapy in the Heart Transplant Recipient: Part I: Cardiac Rejection and Immunosuppressive Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Th1 adaptive immune responses in cardiac graft arteriosclerosis: deleterious or beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Donor-derived IP-10 initiates development of acute allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Organ-Specific Differences in the Function of MCP-1 and CXCR3 During Cardiac and Skin Allograft Rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

High Pretransplant Serum Levels of CXCL10/IP-10 Are Related to Increased Risk of Renal Allograft Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

High CXCL10 Expression in Rejected Kidneys and Predictive Role of Pretransplant Serum CXCL10 for Acute Rejection And Chronic Allograft Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Immunosuppression for heart transplantation: where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Changes of inducible protein-10 and regulated upon activation, normal T cell expressed and secreted protein in acute rejection of pancreas transplantation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

CXC chemokines: the regulatory link between inflammation and angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

CXCR3-binding chemokines: novel multifunctional therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Control of autoimmune diseases by the vitamin D endocrine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Vitamin D as immunomodulatory therapy for kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

The effects of combined treatment with the novel vitamin D analogue MC 1288 and cyclosporine A on cardiac allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Effects of long-term administration of vitamin D3 analogs to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Vitamin D receptor agonists as anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.025

10.1016/J.YEXCR.2008.10.025

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19014933

1 reference

20 December 2017